Funds and ETFs Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Pharmaceuticals

Market Closed - Nyse 04:00:01 2024-04-26 pm EDT 5-day change 1st Jan Change
70.47 USD +0.47% Intraday chart for Prestige Consumer Healthcare Inc. +1.15% +15.11%
Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
70.47 USD
Average target price
74.33 USD
Spread / Average Target
+5.48%
Consensus
  1. Stock Market
  2. Equities
  3. PBH Stock
  4. Funds and ETFs Prestige Consumer Healthcare Inc.